Table 2 Comparison (total sample size N = 658)

Number of items for score determination

8

7

6

6

5

5

5

10

9

5

7

Number of patients with calculated score

658

649

649

649

640

544

607

557

640

625

620

Proportion of patients with score available as compared to full cohort

100.0%

98.6%

98.6%

98.6%

97.3%

82.6%

92.2%

84.6%

97.3%

94.9%

94.2%

Median score, IQR

NA

147

[111–175]

132

[101–156]

94

[73–110]

28

[13–41]

2

[1–3]

2

[1–3]

17

[12–20]

5

[3–6]

9

[6.5–12]

4

[2–5]

AUROC (95% CI)

0.79

[0.76–0.83]

0.87

[0.84–0.90]

0.85

[0.81–0.87]

0.86

[0.83–0.89]

0.84

[0.81–0.88]

0.79

[0.75–0.83]

0.76

[0.71–0.80]

0.88

[0.86–0.91]

0.81

[0.77–0.84]

0.82

[0.78–0.85]

0.85

[0.82–0.88]

Hosmer–Lemeshow

 Absolute value

5.48

11.03

4.83

7.63

11.92

8.84

4.43

12.14

3.84

9.28

16.64

 P-value

0.70

0.19

0.77

0.47

0.15

0.26

0.48

0.14

0.87

0.32

0.03

Comparison versus Utstein

Delta AUROC (95% CI)

NA

0.08

[0.07–0.08]

0.05

[0.04–0.06]

0.07

[0.06–0.07]

0.05

[0.05–0.05]

0

[0–0]

− 0.03

[− 0.03 to 0.05]

0.09

[0.08–0.10]

0.01

[0.01–0.02]

0.02

[0.02–0.03]

0.06

[0.05–0.06]

P-value

< 0.0001

< 0.001

< 0.001

< 0.001

0.28

0.03

< 0.001

0.20

0.16

< 0.001

Added AUROC per item

0.09

0.12

0.14

0.14

0.17

0.16

0.15

0.08

0.09

0.16

0.12